Investing Ideas
/
Swiss Strong Past Earnings Growth, P/E Ratio Below 20

Swiss Strong Past Earnings Growth, P/E Ratio Below 20

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.

12 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
NOVN Novartis	CHF 99.47	1.9%	13.3%	CHF 196.5b	CHF 100.09	PE18.6x	E7.0%	3.4%	Pharmaceuticals & Biotech
ZURN Zurich Insurance Group	CHF 592.20	0.3%	23.7%	CHF 84.3b	CHF 547.52	PE16.4x	E5.7%	4.2%	Insurance
CLN Clariant	CHF 10.83	2.5%	-4.2%	CHF 3.6b	CHF 13.97	PE14.6x	E12.9%	3.9%	Materials
ISN Intershop Holding	CHF 133.00	-4.0%	6.4%	CHF 1.2b	CHF 124.00	PE10.4x	E-20.3%	4.1%	Real Estate Management and Development
JFN Jungfraubahn Holding	CHF 185.00	-0.5%	6.0%	CHF 1.0b	CHF 240.00	PE13.1x	E3.1%	3.5%	Transportation
RIEN Rieter Holding	CHF 87.20	-2.5%	-9.1%	CHF 391.7m	CHF 127.75	PE6.3x	E2.6%	3.4%	Capital Goods
VBSN IVF Hartmann Holding	CHF 140.00	-2.8%	7.7%	CHF 333.4m	n/a	PE16.4x	n/a	2.3%	Healthcare
PNHO Poenina Holding	CHF 51.60	2.4%	-2.6%	CHF 298.8m	n/a	PE17.6x	n/a	4.3%	Capital Goods
OFN Orell Füssli	CHF 82.40	0.7%	11.4%	CHF 161.5m	CHF 82.40	PE18.3x	E15.6%	4.7%	Commercial Services
TIBN Bergbahnen Engelberg-Trübsee-Titlis	CHF 42.00	-0.9%	1.7%	CHF 141.1m	CHF 40.00	PE9.4x	S5.8%	1.9%	Consumer Services
XLS Xlife Sciences	CHF 19.95	2.8%	-55.7%	CHF 114.5m	n/a	PE5.4x	n/a	n/a	Pharmaceuticals & Biotech
ASWN Asmallworld	CHF 1.33	2.3%	-12.5%	CHF 19.5m	CHF 4.00	PE12.5x	E26.8%	n/a	Media

Page 1 of 1